On Friday, during an interview aired at the broadcast of FBN’s “The Claiman Countdown”, Magen CEO Robert Bradway unveiled his company’s decision to invest $ 1 billion in his Columbus, OH, facility.
“How many jobs, construction vs. permanent, will it add part?” Fox Business Network Host Liz Claman asked.
“Well, we are adding an billion dollar investment today, and we hope to rent one and a few hundred employees permanently as a result of this expansion,” Bradway replied. “So, we had about one billion and half invested in Columbus and around 750 people were working in our bio -manufacturing.”
According to Bradway, this step is part of the trend of returning manufacturing in the United States, due to the part of the policies of Trump administration.
“In the period of 2018-2024, we invested about $ 5 billion in manufacturing in the United States, which increased the increment by about $ 12 billion in the United States in the United States,” said a pharmaceutical executive.
Bradway also postponed Trump’s 2017 tax deduction as a launching point for the base of the infrastructure of Magen in the United States.
“Our manufacturing base originated in America,” he said. “And so most of our manufacturing in our business began in the United States. In 2017, tax reforms enabled us to invest in the United States. Therefore, we have continued to increase our manufacturing base here.”
X @jeff_poor follow Jeff Poor
